All Indications Are CMS Plans to Launch its 340B Drug Acquisition Survey on Monday

Editor’s note, March 20, 2020: When we published Tweets of Note yesterday, we were unaware of health care economist’s Rena Conti’s March 14 reply to a critic’s tweet the same day. We have added it to this web version of the article.


As of press time (about 5:00 p.m. Eastern), the Centers for Medicare & Medicaid Services (CMS) had not yet received the green light from the White House to require hospitals, starting this coming Monday March 23, to track their net costs through April 10 for all 340B-purchased drugs billed to Medicare Part B.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

*Sign up for news summaries and alerts from 340B Report

Site Footer